Delivery Order SPE2DR25D3004-SPE2DR26FXYD2

<p>The Defense Logistics Agency issued a $11,536.50 delivery order to AmerisourceBergen Drug Corp on February 3, 2026, for Gel-One 30 mg/3 mL syringes with an ultimate completion date of February 25, 2026.</p> <p>Place of performance is Conshohocken, PA. The order is firm fixed price with no set-aside applied.</p>

<p>The Defense Logistics Agency issued a $15,382 delivery order to AmerisourceBergen Drug Corp on February 5, 2026, for Gel-One 30 mg/3 ml syringes under the company's existing DLA Troop Support Medical indefinite delivery contract.</p> <p>Place of performance is Conshohocken, PA. The order is due for ultimate completion on February 27, 2026, and is priced on a firm fixed-price basis. No set-aside applies.</p>

<p>The Defense Logistics Agency issued a $38,455 delivery order to Amerisourcebergen Drug Corp on February 6, 2026, for supply of Gel-One 30 mg/3 mL syringes, with a completion date of March 2, 2026.</p> <p>Place of performance is Conshohocken, PA. The order carries firm fixed pricing with no set-aside.</p>

<p>The Defense Logistics Agency issued a $1,922.75 delivery order to AmerisourceBergen Drug Corp on February 13, 2026, for Gel-One 30 mg/3 mL syringes under a firm fixed-price arrangement. The order is callable against AmerisourceBergen's Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999 and running through December 2026. Place of performance is Conshohocken, PA. The order is scheduled for completion by March 9, 2026. No set-aside was used.</p>

<p>The Defense Logistics Agency issued a $7,691 delivery order to Amerisourcebergen Drug Corp on February 17, 2026, for Gel-One 30 mg/3 mL syringes. Place of performance is Conshohocken, PA. The order is firm fixed price with an ultimate completion date of March 10, 2026 and no set-aside applied.</p>

On January 14, 2026, the Defense Logistics Agency awarded a delivery order valued at $9,229.20 to AmerisourceBergen Drug Corp for the supply of Gel-One 30 mg/3 mL syringes (3 mL). This firm fixed-price delivery order is not set-aside and will be performed at the contractor's facility in Conshohocken, Pennsylvania, with an ultimate completion date of February 5, 2026. The award represents a task order under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract...

The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 10, 2025, for the supply of Gel-One 30 mg/3 mL syringes in 3 mL quantities, with a contract ceiling value of $3,649.00 and an ultimate completion date of October 1, 2025. This is a firm fixed price delivery order with no set-aside designation, performed at the contractor's location in Conshohocken, Pennsylvania. The award represents a competitively awarded transaction under AmerisourceBergen's...

The Defense Logistics Agency awarded a delivery order valued at $6,921.90 to AmerisourceBergen Drug Corp for the supply of Gel-One 30 mg/3 mL syringes on January 7, 2026, with a completion date of January 29, 2026. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's location in Conshohocken, Pennsylvania. Gel-One is a hyaluronic acid-based intra-articular injection used for the management of osteoarthritis knee...

<p>The Defense Logistics Agency issued a $19,227.50 delivery order to Amerisourcebergen Drug Corp on February 5, 2026, for GEL-ONE 30 mg/3 mL syringes under a firm fixed-price contract with an ultimate completion date of February 27, 2026.</p> <p>Place of performance is Conshohocken, PA. The order was issued without a set-aside. Amerisourcebergen Drug Corp is a subsidiary of Cencora, Inc.</p>

The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on September 17, 2025, for the supply of Gel-One 30 mg/3 mL syringes with a ceiling value of $10,947.00 and ultimate completion date of October 8, 2025. This is a firm fixed-price delivery order with no set-aside designation, awarded through open competition. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its corporate headquarters. Gel-One is...